Archives

by in
Entry Author Date Location
Sarepta’s Muscular Dystrophy Drug Improves With Time; Stock Booms 07/24/12 Seattle
After Big Oops, Vertex Plows Ahead With Cystic Fibrosis Drug Combo 06/28/12 Boston
Acucela, Turning 10, Gears Up for Pivotal Test With Eye Drug 06/12/12 Seattle
Basic Biology: The Complex Core of Drug Discovery 05/30/12 Seattle
Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data 05/29/12 Boston
Safety Analyses Lead Sangart to Move Ahead with ‘Oxygen Therapeutic’ 05/29/12 San Diego
MediciNova Misses Primary Goal in Mid-Stage Trial of IV Asthma Drug 05/23/12 San Diego
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 05/23/12 Seattle
CardioKinetix Clears 2-Year Study with Implant for Heart Failure 05/18/12 San Francisco
Theraclone Passes First Clinical Test with Flu-Fighting Antibody 05/15/12 Seattle
Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig’s Disease 04/25/12 San Francisco
AVI Biopharma Passes Small Study in Muscular Dystrophy 04/02/12 Seattle
Omeros Bounces Back With Drug For Eye Surgeries; Shares Climb 03/13/12 Seattle
Aastrom Closes $40 Million Financing Deal with Eastern Capital 03/09/12 Detroit
EPA Expands Innovative Compound-Testing Collaboration With BioSeek 02/15/12 Detroit
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall 01/27/12 Boston
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls 01/03/12 Boston
Aastrom Reports Positive Phase 2 Trial Results 11/15/11 Detroit
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic 09/21/11 Seattle
Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News 09/21/11 Boston
Zogenix Pain Drug Meets Endpoint 08/17/11 San Diego
AVI Starts Duchenne Trial 08/15/11 Seattle
Meritage Pharma Passes Key Test With Drug to Reduce Swelling of the Food Pipe 05/10/11 San Diego
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
Sangart Gets $50M Infusion for Oxygen-Carrying Blood Adjunct 04/19/11 San Diego
Gilead Drug Fails AIDS Prevention Trial 04/18/11 San Francisco
Biotech’s Missed Opportunity: Small-Town and Rural America 04/18/11 National
Public Policy Institute on How to Boost Biotech in New York: More Jobs, Better Teamwork, Fewer Taxes 04/12/11 New York
Biogen Idec Passes Pivotal Trial With Oral MS Drug; Shares Climb 04/11/11 Boston
Page 2 of 9 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. When iMovie Isn’t Enough, Amateur Video Producers Can Go Pro

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.